Hims stock surged Tuesday after the compounding pharmacy said it would sell Eli Lilly's branded weight-loss drug on its ...

Telehealth firm Hims & Hers Health said on Tuesday it plans to sell Eli Lilly's diabetes and weight-loss drugs on its ...

Hims & Hers Health (NYSE:HIMS) stock gains as the company adds Eli Lilly's (LLY) weight loss therapy tirzepatide & generic ...

Hims & Hers Health (NYSE:HIMS) has taken investors on a wild ride in 2025. The stock surged nearly 200% earlier this year, ...

Shares of the health and wellness platform operator skyrocketed more than 670% between Jan. 1, 2024, and Feb. 19, 2025.

Hims & Hers Health (HIMS) stock enjoyed a 10% jump in price last week on news that the company plans to continue offering ...

Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

The company’s stock rise reflects investor optimism following the news that Hims & Hers will provide both branded versions of ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Telehealth providers like Hims and Ro say they are helping fill the gap. The companies' business model offers patients quick ...

Explore what to expect now that the Hims & Hers stock price now that it has crashed hard in the past few weeks.

Hims shares gained as much as 14% in New York, their biggest gain since Feb. 19.